Related references
Note: Only part of the references are listed.68Ga-PSMA-HBED-CC PET/CT: where molecular imaging has an edge over morphological imaging
Felix M. Mottaghy et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients
Florian Sterzing et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data
Stefano Fanti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
68Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment
Pim J. van Leeuwen et al.
BJU INTERNATIONAL (2016)
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Christina Bluemel et al.
CLINICAL NUCLEAR MEDICINE (2016)
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
Tiziano Graziani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature
Laura Evangelista et al.
EUROPEAN UROLOGY (2016)
Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
Piet Ost et al.
EUROPEAN UROLOGY (2016)
Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
Wolfgang P. Fendler et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Integration of 68Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study
Sabrina Dewes et al.
RADIATION ONCOLOGY (2016)
68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer
Christoph Henkenberens et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Francesco Ceci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature
Piet Ost et al.
EUROPEAN UROLOGY (2015)
Contemporary Role of Salvage Lymphadenectomy in Patients with Recurrence Following Radical Prostatectomy
Firas Abdollah et al.
EUROPEAN UROLOGY (2015)
Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy
Ken Herrmann et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Prospective Comparison of F-18-Fluoromethylcholine Versus Ga-68-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
Joshua J. Morigi et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists
Thomas P. Shakespeare
RADIATION ONCOLOGY (2015)
[68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice
Thomas Krohn et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer
M. Picchio et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Axel Heidenreich et al.
EUROPEAN UROLOGY (2014)
Early Salvage Radiotherapy Following Radical Prostatectomy
David Pfister et al.
EUROPEAN UROLOGY (2014)
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
Martina Weineisen et al.
EJNMMI RESEARCH (2014)
Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer A Systematic Review and Meta-Analysis
Laura Evangelista et al.
CLINICAL NUCLEAR MEDICINE (2013)
The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis
Martin H. Umbehr et al.
EUROPEAN UROLOGY (2013)
Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines
Richard K. Valicenti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Impact of Biochemical Recurrence in Prostate Cancer Among US Veterans
Edward M. Uchio et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Is the Roach formula predictive for biochemical outcome in prostate cancer patients with minimal residual disease undergoing local radiotherapy after radical prostatectomy?
Gregor Goldner et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation
Martin Spahn et al.
UROLOGIA INTERNATIONALIS (2010)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
B. J. Krause et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Radiotherapy after prostatectomy: Improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
Michael T. Spiotto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group
Philip Poortmans et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Predominant treatment failure in postprostatectomy patients is local: Analysis of patterns of treatment failure in SWOG 8794
Gregory P. Swanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Is there a favorable subset of patients with prostate cancer who develop oligometastases?
D Singh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy
CJ Kane et al.
UROLOGY (2003)
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
M Han et al.
JOURNAL OF UROLOGY (2003)
Share Paper
